NBIX
Neurocrine Biosciences Inc
Price:  
131.30 
USD
Volume:  
1,410,837.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBIX EV/EBITDA

-41.4%
Upside

As of 2024-03-03, the EV/EBITDA ratio of Neurocrine Biosciences Inc (NBIX) is 29.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NBIX's latest enterprise value is 12,204.16 mil USD. NBIX's TTM EBITDA according to its financial statements is 419.60 mil USD. Dividing these 2 quantities gives us the above NBIX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.1x - 22.4x 18.2x
Forward P/E multiples 17.3x - 25.5x 20.6x
Fair Price 58.96 - 103.11 76.88
Upside -55.1% - -21.5% -41.4%
131.30 USD
Stock Price
76.88 USD
Fair Price

NBIX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-01 29.09
2024-02-29 28.87
2024-02-28 29.88
2024-02-27 30.21
2024-02-26 30.10
2024-02-23 29.77
2024-02-22 29.58
2024-02-21 28.93
2024-02-20 29.41
2024-02-16 29.32
2024-02-15 29.73
2024-02-14 29.20
2024-02-13 29.69
2024-02-12 28.88
2024-02-09 29.32
2024-02-08 29.83
2024-02-07 30.27
2024-02-06 31.85
2024-02-05 31.54
2024-02-02 31.56
2024-02-01 31.73
2024-01-31 31.09
2024-01-30 31.64
2024-01-29 31.67
2024-01-26 31.66
2024-01-25 31.39
2024-01-24 31.17
2024-01-23 31.25
2024-01-22 31.10
2024-01-19 30.52
2024-01-18 30.38
2024-01-17 30.47
2024-01-16 29.40
2024-01-12 29.26
2024-01-11 28.91
2024-01-10 29.34
2024-01-09 29.66
2024-01-08 29.71
2024-01-05 29.37
2024-01-04 29.63
2024-01-03 29.42
2024-01-02 29.19
2023-12-29 29.19
2023-12-28 29.29
2023-12-27 29.43
2023-12-26 29.06
2023-12-22 28.41
2023-12-21 26.68
2023-12-20 26.48
2023-12-19 26.76